全球生物活性材料市場規模、佔有率、成長分析（按類型、按應用） - 產業預測，2023-2030 年

Global Bioactive Materials Market Size, Share, Growth Analysis, By Type(Natural Biomaterial, Metallic Biomaterial), By Application(Neurology, Cardiology) - Industry Forecast 2023-2030

出版日期: 2024年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球生物活性材料市場規模估值為22.6億美元，從2023年的25.5億美元成長到2031年的67.9億美元，在預測期內（2024-2031年）預計年複合成長率為13 %。

由於對先進植入材料的需求不斷增加以及對傳統金屬植入的擔憂日益增加，導致市場出現模式轉移成長的跡象。生物活性材料以其與體液和組織的強結合能力而聞名，在用於組織癒合和修復的醫療和醫學領域以及抗菌產品、藥品和化妝品的生產中越來越受歡迎。為此，刺激市場的擴大。憑藉細胞移植、修復、再生和重組的專業化，在各種整形外科手術和生物工程計劃中的廣泛採用對於推動市場向前發展非常重要。儘管耐磨損、耐細菌滲透和防潮，但市場擴張可能會受到先進加工工具和技術需要大量初始投資的限制。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東、非洲
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區

競爭格局

前5名企業比較
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Medtronic plc（愛爾蘭）
Evonik Industries AG（德國）
Carpenter Technology Corporation（美國）
Berkeley Advanced Biomaterials（美國）
Invibio Ltd（英國）
Zimmer Biomet Holdings, Inc.（美國）
BASF SE（德國）
Covalon Technologies Ltd（加拿大）
Stryker（美國）
Johnson & Johnson（美國）
Dentsply Sirona（美國）
CoorsTek Inc.（美國）
Corbion（荷蘭）
Royal DSM NV（荷蘭）
3M Company（美國）
Amedica Corporation（美國）
Ceramtec GmbH（德國）
Cam Bioceramics（韓國）
Alphatec Spine, Inc.（美國）
Wright Medical Group, Inc.（美國）

簡介目錄

Product Code: SQMIG35H2177

Global Bioactive Materials Market size was valued at USD 2.26 billion in 2022 and is poised to grow from USD 2.55 billion in 2023 to USD 6.79 billion by 2031, growing at a CAGR of 13% during the forecast period (2024-2031).

The market is on the cusp of significant growth driven by escalating demand for advanced implantable materials and growing apprehensions about traditional metal implants, prompting a paradigm shift. Bioactive materials, renowned for their robust bonding capabilities with fluids and tissues, are increasingly sought after in medical and healthcare domains for tissue healing and repair, as well as in the production of antibacterial products, pharmaceuticals, and cosmetics, thereby fueling market expansion. Their widespread adoption in various orthopedic surgeries and bioengineering endeavors is pivotal in advancing the market, given their specialization in cellular transplants, repair, regeneration, and reconstruction. Despite their resilience to wear, bacterial infiltration, and moisture, the market's expansion might be tempered by the significant initial investment required for sophisticated processing tools and technology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioactive Materials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioactive Materials Market Segmental Analysis

The global bioactive materials market is segmented on the basis of type, application, region. By type, the market is segmented into powder, moldable, granules, and others. By application, the market is segmented into dentistry, surgery, bioengineering, others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Bioactive Materials Market

One of the primary factors driving the Global Bioactive Materials Market is the rising demand within the healthcare sector, particularly for orthopedic surgeries and tissue engineering applications. The increasing focus on advanced implantable materials that demonstrate strong bonding capabilities with fluids and tissues has led to bioactive materials becoming favored by both medical practitioners and researchers. Their effectiveness in tissue healing, repair, and regeneration, along with their potential for producing antibacterial products, pharmaceuticals, and cosmetics, further solidifies their market demand. With healthcare technologies advancing and concerns regarding traditional metal implants remaining, bioactive materials are poised to experience continuous growth in the foreseeable future.

Restraints in the Global Bioactive Materials Market

A major impediment facing the Global Bioactive Materials Market is the significant expenses tied to research and development (R&D). The creation of bioactive materials requires thorough research, experimentation, and validation procedures to guarantee their effectiveness, safety, and adherence to regulatory requirements, necessitating substantial investments in advanced laboratories, specialized equipment, expert staff, and clinical trials. Moreover, the ongoing demand for innovation and enhancement to maintain competitiveness exacerbates R&D spending. Consequently, the substantial R&D costs present a substantial obstacle for smaller enterprises and startups seeking entry into the market, potentially constraining overall market growth despite its optimistic outlook.

Market Trends of the Global Bioactive Materials Market

An emerging trend in the global bioactive materials market is the integration of nanotechnology, which involves manipulating materials at the nanoscale to enhance their properties and performance. Nanotechnology offers the potential to revolutionize bioactive materials by enabling precise control over their structure and functionality, leading to improvements in biocompatibility, durability, and therapeutic efficacy. Through the incorporation of nanoparticles and nanostructures, bioactive materials can achieve enhanced drug delivery, tissue regeneration, and antimicrobial properties, opening up new opportunities for applications in medical implants, drug delivery systems, and tissue engineering. As research and development in nanotechnology continue to advance, the integration of nanomaterials is expected to drive innovation and competitiveness within the global bioactive materials market, further propelling its growth and expansion.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Bioactive Materials Market by Type

Market Overview
Natural Biomaterial
Metallic Biomaterial
Ceramic Biomaterial
and Polymeric Biomaterial

Global Bioactive Materials Market by Application

Market Overview
Neurology
Cardiology
Orthopedics
Ophthalmology
Wound Care
Dental
Plastic Surgery
and Other Applications

Global Bioactive Materials Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carpenter Technology Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berkeley Advanced Biomaterials (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invibio Ltd (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covalon Technologies Ltd (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dentsply Sirona (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CoorsTek Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corbion (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Royal DSM NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amedica Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceramtec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cam Bioceramics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alphatec Spine, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wright Medical Group, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments